三箭生物官网

SUNGENE expands the scope of production

In May 13, 2013, Tianjin Sungene biotech Co., Ltd. formally expand the production scope.

Since Tianjin Sungene biotech Co., Ltd. obtained "People's Republic of China medical equipment manufacturing enterprises licence" issued by Food and Drug Administration in November 29th, 2012, SUNGENE Biotech constantly improve the product quality, and make new progress in R&D. In May 13, 2013, Tianjin Food and Drug Administration formally approved SUNGENE Biotech to expand the production scope.

The progress demonstrates constantly optimizing results of Sungene biotech itself. Since then, Sungene Biotech can have more complete product types, more space of production and sales, and updated research projects. It can promote further for the goal of international company in the antibody reagents. Tianjin Sungene biotech Co., Ltd. will also gradually develop in the clinical market.

Go back to previous page

Previous chapter: SUNGENE biotech gain...

Next chapter: Sungene biotech intr...Publication date： 2013-05-23